Probiotic Prawn Oral Immunotherapy (ProPIT) For Treatment Of Prawn Allergy
Funder
National Health and Medical Research Council
Funding Amount
$1,865,369.00
Summary
A ‘curative’ food allergy treatment is needed to prevent deaths and improve care. We recently showed that probiotic peanut oral immunotherapy (PPOIT) was highly effective for treating peanut allergy. 82% of PPOIT treated children gained tolerance compared to 4% of the placebo group. We will now test the combined probiotic-food OIT approach for treating prawn allergy. If successful, we will have identified the first treatment for prawn allergy and a platform treatment for other food allergies.
Maternal Diet Rich In Eggs And Peanuts To Reduce Food Allergies: A Randomised Controlled Trial.
Funder
National Health and Medical Research Council
Funding Amount
$3,719,516.00
Summary
Food allergies now affect more than 1 in every 10 children. Recently, babies have been found to be at risk of developing a food allergy even before they start eating solid foods. We have discovered that baby immune responses can be improved by mothers eating more eggs during the first weeks of breastfeeding. Thus we are undertaking this research trial to determine whether mothers regularly eating more eggs and peanuts during pregnancy and breastfeeding will reduce food allergies in their babies.
Dietary Modulation Of Maternal Gut Flora With Oligosaccharides In Pregnancy As A Novel Allergy Prevention Strategy
Funder
National Health and Medical Research Council
Funding Amount
$1,681,512.00
Summary
Declining intake of dietary fibre is a major factor implicated in the changing profile of healthy gut bacteria, and the associated increase in many inflammatory diseases including childhood allergy. This clinical trial aims to confirm findings in animal studies that increased dietary fibre in pregnancy can prevent allergy in the offspring, by favourably influencing metabolism and immune function during pregnancy.
Phase I/IIa Trials Of A Novel T-cell Epitope-based Peptide Therapy For Peanut Allergy
Funder
National Health and Medical Research Council
Funding Amount
$1,440,000.00
Summary
Peanut allergy affects ~2% of the population and is the major cause of food triggered deaths from anaphylaxis. Typically peanut allergy is lifelong. Currently there is no specific treatment. Our vast experience in immunology for house dust mite and grass immunotherapy allowed us to identify critical components of peanut proteins needed as a safe vaccine to build tolerance to peanut foods. Now we will progress this novel and revolutionary vaccine through early phase clinical trials.